LDL oxidation and human placental trophoblast and macrophage cytotoxicity

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 2, 1998, Pages 203-211

  Bonet, Bartolome ^a   Hauge Gillenwater, Heidi ^b   Zhu, Xiao Dong ^c   Knopp, Robert H ^c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER CHLORIDE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGING; ARTICLE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; PLACENTA FUNCTION; TROPHOBLAST;

EID: 0031891126     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44224     Document Type: Article

References (47)

1. Bonet B, Knopp RH, Brunzell J, Gown A. Metabolism of very low-density lipoprotein triglyceride by human placental cells: The role of lipoprotein lipase. Metabolism 41:596-603, 1992.
2. 2 stimulation of progesterone secretion in cultured placental trophoblast. J Lipid Res 32:1073-1087, 1991.
3. 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the 39-kd receptor-associated protein in human trophoblasts. Am J Pathol 144(2):383-392, 1994.
4. Bonet B, Chait A, Gown AM, Knopp RH. Metabolism of modified LDL by cultured human placental cells. Atherosclerosis 112:125-136, 1995.
5. Ishihara M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta 84:1-9, 1978.
6. Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy TL. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 18:158-162, 1981.
7. Uotila J, Tuimala R, Aarnio T, Pyykko K, Ahotupa M. Lipid peroxidation products, selenium-dependent glutathione peroxidase and vitamin E in normal pregnancy. Eur J Obstet Gynaecol Reprod Biol 42:95-100, 1991.
8. Bonet B, Knopp RH. Accelerated LDL oxidation in diabetic gestation. Program of the 2nd International Graz Symposium on Gestational Diabetes, Graz, Oct. 12-16, 1992.
9. Carone D, Loverro G, Greco P, apuano P, Selvaggi L. Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 51:103-109, 1993.
10. Maseki M, Nishgaki I, Hogihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid serum content of serum lipoprotein fractions of pregnant subjects with and without pre-eclampsia. Clin Chim Acta 155:155-161, 1981.
11. Tsukatani E. Etiology of EPH-gestosis from the viewpoint of dynamics of vasoactive prostanoid, lipid peroxides and vitamin E. Acta Obstet Gynecol Jpn 35:713-720, 1983.
12. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 169:1462-1466, 1993.
13. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161:1025-1034, 1989.
14. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Preeclampsia and serum antibodies to oxidized low-density lipoprotein. Lancet 343:645-646, 1994.
15. Zhu X-D, Bonet B, Knopp RH. 17-β-estradiol, progesterone and testosterone inversely modulate LDL oxidation and cytotoxicity in cultured placental trophoblast and macrophages. Am J Obstet Gynecol 177:196-209, 1997.
16. Hessler JR, Morel DW, Lewis LJ, Chisolm GY. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215-22, 1983.
17. Chisolm GM. Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 2:311-316, 1991.
18. Henriksen T, Evensen SA, Carlander B. Injury to human endothelial cells in culture induced by low-density lipoproteins. Scand J Clin Lab Invest 39:361-368, 1979.
19. Morel DW, Hessler JR, Chisolm JM. Low-density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24:1070-1076, 1983.
20. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320(14):915-924, 1989.
21. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9:155-168, 1990.
22. Hauge-Gillenwater H, Bonet B, Meekins D, Knopp RH. Cytotoxic effects of LDL and oxidized LDL on placental macrophages and trophoblast. Clin Res 41:26A, 1993.
23. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
24. Schuh J, Fanclough GF Jr., Haschemeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 75(7):3173-3177, 1978.
25. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassay AY, Jürgens G. A. spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627-630, 1989.
26. Lipid Research Clinics Program. Manual of Laboratory Operations, 2nd Ed. In: Hainline A, Karon J, Lippel K, Eds. Bethesda, MD: National Heart Lung and Blood Institute, pp107-115, 1982.
27. Snedecor GW, Cochran WG. Statistical Methods, 6th Ed. Ames, IA: Iowa State Univ. Press, pp91-119, 1967.
28. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 167:946-949, 1992.
29. Hay WW Jr. Placental nutrient metabolism and transport. In: Herrera E, Knopp RH, Eds. Perinatal Biochemistry. Boca Raton, FL: Chemical Rubber Publishing Co., pp93-130, 1992.
30. Alsat E, Mondon F, Rebourcet R, Berthelier M, Erlich D, Cedard L, Goldstein S. Identification of specific binding sites for acetylated low-density lipoprotein in microvillous membranes from human placenta. Mol Cell Endocrinol 41:229-235, 1985.
31. Malassine A, Alsat E, Besse C, Rebourcet R, Cedard L. Acetylated low-density lipoprotein endocytosis by human syncytiotrophoblast in culture. Placenta 11:191, 1990.
32. Henriksen T, Evensen SA, Carlander B. Injury to human endothelial cells in culture induced by low-density lipoproteins. Scand J Clin Lab Invest 39:361-368, 1979.
33. Hessler JR, Morel DW, Lewis LJ, Chisolm GY. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215-222, 1983.
34. Morel DW, Hessler JR, Chisolm JM. Low-density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24:1070-1076, 1983.
35. Chisolm GM. Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 2:311-316, 1991.
36. Cranfield LM, Gollan JL, White AG, Dormandy TL. Serum antioxidant activity in normal and abnormal subjects. Ann Clin Biochem 16:299-306, 1979.
37. Mead JF, Alfin-Slater RB, Hoston DR, Popjack G. Peroxidation of fatty acids. In: Lipids: Chemistry, Biochemistry, and Nutrition. New York: Plenum Press pp83-99, 1986.
38. Hennig B, Chow CK. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Free Radic Biol Med 4:99-106, 1988.
39. 2-Isoprostanes) in smokers. N Engl J Med 332:1198-1203, 1995.
40. Honda M, Toyoda C, Nakabayashi M, Omori Y. Quantitative investigations of placental terminal villi in maternal diabetes mellitus by scanning and transmission electron microscopy. Tohoku J Exp Med 167:247-257, 1992.
41. Braunstein GD, Mills JL, Reed GF, Jovanovic LG, Holmes LB, Aarons J, Simpson JL, and the NICHD Diabetes in Early Pregnancy Study Group J.L.M. Comparison of serum placental protein hormone levels in diabetic and normal pregnancy. J Clin Endocrinol Metab 68:3-8, 1989.
42. Fox H. Pathology of the placenta in maternal diabetes mellitus. Obstet Gynecol 34:792-798, 1969.
43. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 169:1112-1118, 1993.
44. Brown HL, Miller JM Jr., Khawli O, Gabert HA. Premature placental calcification in maternal cigarette smokers. Obstet Gynecol 71:914-917, 1988.
45. Jauniaux E, Burton GJ. The effect of smoking in pregnancy on early placental morphology. Obstet Gynecol 79:645-648, 1992.
46. Eriksson UJ, Borg AH. Diabetes and embryonic malformations: Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryo. Diabetes 42:411-419, 1993.
47. Viana M, Herrera E, Bonet B. Teratogenetic effects of diabetes mellitus in the rat: Prevention by vitamin E. Diabetologia 39:1041-1046, 1996.